- Home
- SOTK vs INZY Comparison
SOTK vs INZY Comparison
Compare SOTK & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- INZY
- Stock Information
- Founded
- SOTK 1975
- INZY 2015
- Country
- SOTK United States
- INZY United States
- Employees
- SOTK N/A
- INZY N/A
- Industry
- SOTK Industrial Machinery/Components
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- INZY Health Care
- Exchange
- SOTK Nasdaq
- INZY Nasdaq
- Market Cap
- SOTK 58.1M
- INZY 64.9M
- IPO Year
- SOTK 1987
- INZY 2020
- Fundamental
- Price
- SOTK $3.96
- INZY $0.98
- Analyst Decision
- SOTK Buy
- INZY Strong Buy
- Analyst Count
- SOTK 1
- INZY 9
- Target Price
- SOTK $7.50
- INZY $17.22
- AVG Volume (30 Days)
- SOTK 6.1K
- INZY 451.6K
- Earning Date
- SOTK 05-22-2025
- INZY 05-06-2025
- Dividend Yield
- SOTK N/A
- INZY N/A
- EPS Growth
- SOTK N/A
- INZY N/A
- EPS
- SOTK 0.07
- INZY N/A
- Revenue
- SOTK $20,151,145.00
- INZY N/A
- Revenue This Year
- SOTK $6.11
- INZY N/A
- Revenue Next Year
- SOTK $9.27
- INZY N/A
- P/E Ratio
- SOTK $55.87
- INZY N/A
- Revenue Growth
- SOTK 8.40
- INZY N/A
- 52 Week Low
- SOTK $3.50
- INZY $0.72
- 52 Week High
- SOTK $6.05
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- SOTK 70.44
- INZY 49.52
- Support Level
- SOTK $3.50
- INZY $0.90
- Resistance Level
- SOTK $3.76
- INZY $1.08
- Average True Range (ATR)
- SOTK 0.13
- INZY 0.11
- MACD
- SOTK 0.05
- INZY 0.03
- Stochastic Oscillator
- SOTK 100.00
- INZY 72.31
About SOTK Sono-Tek Corporation
Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.